---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002646"
form_type: "8-K"
ticker: "TRUG"
cik: "0001857086"
company_name: "TruGolf Holdings, Inc."
filed_at: "2023-01-26T23:59:59+00:00"
generated_at: "2026-06-20T08:31:31.914367+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Deep Medicine Acquisition Corp. receives Nasdaq delisting notice for insufficient publicly held shares

## Summary
- Received Nasdaq notice on Jan 22, 2023 for failure to meet minimum 1,100,000 publicly held shares (Listing Rule 5450(b)(2)).
- Deficiency triggered by stockholder redemptions at the last meeting; company has until March 9, 2023 to submit a compliance plan.
- If Nasdaq accepts the plan, it may grant up to 180 days from the notice date to evidence compliance.
- Company is exploring all options to regain listing compliance; failure could lead to delisting via appeal process.

## SEC filing metadata
- accession: 0001493152-23-002646
- form_type: 8-K
- ticker: TRUG
- cik: 0001857086
- company_name: TruGolf Holdings, Inc.
- filed_at: 2023-01-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857086/000149315223002646/0001493152-23-002646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857086/000149315223002646/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002646
- JSON: https://secwatch.observer/filing/0001493152-23-002646.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002646.txt

## Key facts
- Listing & Compliance Notices
  TruGolf Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5450(b)(2)
  source text: January 22, 2023, Deep Medicine Acquisition Corp., a Delaware corporation (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that, following the stockholder redemptions at the Company’s last stockholder meeting, the Company is not in compliance with Listing Rule 5450(b)(2), due to the Company’s failure to meet the minimum 1,100,000 publicly held shares requirement for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, an
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857086/000149315223002646/0001493152-23-002646-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.